keyword
https://read.qxmd.com/read/38652565/renal-cell-carcinoma-histologic-subtypes-exhibit-distinct-transcriptional-profiles
#1
JOURNAL ARTICLE
Pedro Barata, Shuchi Gulati, Andrew Elliott, Hans J Hammers, Earle F Burgess, Benjamin A Gartrell, Sourat Darabi, Mehmet A Bilen, Arnab Basu, Daniel M Geynisman, Nancy A Dawson, Matthew R Zibelman, Tian Zhang, Shuanzeng Wei, Charles J Ryan, Elisabeth I Heath, Kelsey A Poorman, Chadi Nabhan, Rana R McKay
Molecular profiling of clear cell RCC (ccRCC) tumors of clinical trial patients has identified distinct transcriptomic signatures with predictive value, yet data in non-clear cell variants (nccRCC) are lacking. We examined the transcriptional profiles of RCC tumors representing key molecular pathways, from a multi-institutional, real-world patient cohort, including ccRCC (n = 508) and centrally-reviewed nccRCC (n = 149) samples. ccRCC had increased angiogenesis signature scores compared to the heterogeneous group of nccRCC tumors (mean z-score 0...
April 23, 2024: Journal of Clinical Investigation
https://read.qxmd.com/read/38652459/telemedicine-in-geriatric-oncology-lessons-learned-from-the-covid-19-experience
#2
JOURNAL ARTICLE
Leana Cabrera Chien, Carolina Uranga, Vani Katheria
PURPOSE OF REVIEW: Telemedicine quickly became integrated into healthcare caused by the Coronavirus 19 (COVID-19) pandemic. Rapid use of telemedicine into healthcare systems was supported by the World Health Organization and other prominent national organizations to reduce transmission of the virus while continuing to provide access to care. In this review, we explored the effect of this swift change in care and its impact on older adults with cancer. RECENT FINDINGS: Older adults are susceptible to the COVID-19 virus caused by various risk factors, such as comorbidity, frailty, decreased immunity, and cancer increases vulnerability to infection, hospitalization, and mortality...
April 23, 2024: Current Opinion in Supportive and Palliative Care
https://read.qxmd.com/read/38652311/the-landsteiner-lung-cancer-research-platform-laluca-objectives-methodology-and-implementation-of-a%C3%A2-real-world-clinical-lung-cancer-registry
#3
JOURNAL ARTICLE
Anna Lang-Stöberl, Hannah Fabikan, Maximilan Hochmair, Klaus Kirchbacher, Vikaela Mania Rodriguez, Leya Ay, Christoph Weinlinger, David Rosenthaler, Oliver Illini, Nino Müser, Georg-Christian Funk, Arschang Valipour
BACKGROUND: Lung cancer is a major health burden in Austria; however, limited real-world data exist on the diagnostic and treatment reality of lung cancer patients in Austria. The collection of high-quality data in a clinical setting is needed to gain insights into the real-world diagnostic and therapeutic management of lung cancer patients. METHODS: The Karl Landsteiner Institute for Lung Research and Pulmonary Oncology implemented the Landsteiner lung cancer research platform (LALUCA), recruiting unselected lung cancer patients from two high volume centers in Vienna...
April 23, 2024: Wiener Klinische Wochenschrift
https://read.qxmd.com/read/38652275/the-safety-and-efficacy-of-neoadjuvant-immunochemotherapy-following-laparoscopic-gastrectomy-for-gastric-cancer-a-multicenter-real-world-clinical-study
#4
JOURNAL ARTICLE
Yu-Qin Sun, Qing Zhong, Chen-Bin Lv, Ji-Yun Zhu, Guang-Tan Lin, Zhi-Quan Zhang, Dong Wu, Cai-Ming Weng, Qiu-Xian Chen, Ming-Qiao Lian, Wei-Ming Zeng, Yong-Bin Zhang, Qi-Yue Chen, Jian-Xian Lin, Jian-Wei Xie, Ping Li, Chao-Hui Zheng, Jun Lu, Li-Sheng Cai, Chang-Ming Huang
BACKGROUND: The safety and efficacy of neoadjuvant immunochemotherapy (nICT) for locally advanced gastric cancer (LAGC) remain controversial. METHODS: Patients with LAGC who received either nICT or neoadjuvant chemotherapy (nCT) at 3 tertiary referral teaching hospitals in China between January 2016 and October 2022 were analysed. After propensity-score matching (PSM), comparing the radiological response, pathological response rate, perioperative outcomes, and early recurrence between the two groups...
April 23, 2024: International Journal of Surgery
https://read.qxmd.com/read/38651937/molecular-classification-and-intratumoral-heterogeneity-of-gastric-adenocarcinoma
#5
REVIEW
Takeshi Kuwata
Gastric cancers frequently harbor striking histological complexity and diversity between lesions as well as within single lesions, known as inter- and intratumoral heterogeneity, respectively. The latest World Health Organization Classification of Tumors designated more than 30 histological subtypes for gastric epithelial tumors, assigning 12 subtypes for gastric adenocarcinoma (GAD). Meanwhile, recent advances in genome-wide analyses have provided molecular aspects to the histological classification of GAD, and consequently revealed different molecular traits underlying these histological subtypes...
April 23, 2024: Pathology International
https://read.qxmd.com/read/38651936/a-machine-learning-approach-for-predicting-textbook-outcome-after-cytoreductive-surgery-and-hyperthermic-intraperitoneal-chemotherapy
#6
JOURNAL ARTICLE
Amir Ashraf Ganjouei, Fernanda Romero-Hernandez, Jaeyun Jane Wang, Ahmed Hamed, Ahmed Alaa, David Bartlett, Adnan Alseidi, Mohammad Haroon Choudry, Mohamed Adam
INTRODUCTION: Peritoneal carcinomatosis is considered a late-stage manifestation of neoplastic diseases. Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS-HIPEC) can be an effective treatment for these patients. However, the procedure is associated with significant morbidity. Our aim was to develop a machine learning model to predict the probability of achieving textbook outcome (TO) after CRS-HIPEC using only preoperatively known variables. METHODS: Adult patients with peritoneal carcinomatosis and who underwent CRS-HIPEC were included from a large, single-center, prospectively maintained dataset (2001-2020)...
April 23, 2024: World Journal of Surgery
https://read.qxmd.com/read/38651760/top-advances-of-the-year-cervical-cancer
#7
JOURNAL ARTICLE
Linda R Duska, Sarah E Podwika, Leslie M Randall
The year 2023 was an extraordinary year for the further development and expansion of novel treatments for all patients with cervical cancer, ranging from early stage to later stage and metastatic or recurrent disease. Individuals with early-stage disease will benefit from less invasive surgery with subsequent improvement in quality of life. The effectiveness of immunotherapy has been demonstrated in upfront, locally advanced cervical cancer and confirmed in advanced metastatic disease. Induction chemotherapy will play a role in some patients with locally advanced disease, particularly those in low resource areas of the world...
April 23, 2024: Cancer
https://read.qxmd.com/read/38651600/occult-appendix-pathology-in-patients-undergoing-colorectal-cancer-resection-and-prophylactic-appendectomy
#8
JOURNAL ARTICLE
Francesco Di Fabio, Prabhu Ravi, Niccolo Allievi, Kashuf A Khan, Abu Abduelraheim, Brendan Moran
BACKGROUND: The risk-benefit balance of prophylactic appendectomy in patients undergoing left colorectal cancer resection is unclear. The aim of this report is to assess the proportion of histologically abnormal appendices in patients undergoing colorectal cancer resection in a unit where standard of care is appendectomy, with consent, when left-sided resection is performed. METHODS: A retrospective study on a prospectively collected database was conducted in a single tertiary-care center...
January 2024: World Journal of Surgery
https://read.qxmd.com/read/38651260/investigational-drugs-for-the-treatment-of-acromegaly-new-agents-to-transform-therapy
#9
REVIEW
Rosa Pirchio, Renata S Auriemma, Alice Vergura, Rosario Pivonello, Annamaria Colao
INTRODUCTION: Disease control is essential to decrease morbidity burden and mortality in acromegaly patients. In the last decades, the availability of new drugs increased the rate of disease control. However, up to 55% of patients remain uncontrolled despite available treatment strategies in real-world data. The reasons for this finding may include poor adherence, inadequate tolerability, therapeutic inertia, and high costs. Since acromegaly is a chronic disease and medical therapy is usually life-long, patient's adherence to treatment is fundamental in both achieving and maintaining disease control...
April 23, 2024: Expert Opinion on Investigational Drugs
https://read.qxmd.com/read/38651177/effectiveness-and-infectious-complications-of-bcma-t-cell-engagers-in-treating-multiple-myeloma-real-world-evidence-from-sweden
#10
JOURNAL ARTICLE
Katarina Uttervall, Love Tätting, Konstantinos Lemonakis, Mousa Majd, Jacob Crafoord, Mikael Olsson, Ulf-Henrik Mellqvist, Markus Hansson, Hareth Nahi
BACKGROUND: Multiple myeloma (MM), an incurable disease characterized by frequent relapses and a need for multiple treatments, often progresses to a relapse/refractory status resistant to all available drugs and drug classes. Bispecific antibodies, specifically BCMA T-cell engagers, have emerged as effective treatments for MM, demonstrating impressive efficacy. However, these treatments can adversely affect the immune system, increasing vulnerability to infections. METHODS/RESULTS: This study evaluated the efficacy and safety of BCMA T-cell engagers in 58 Swedish patients with poor MM prognosis...
April 2024: Cancer Medicine
https://read.qxmd.com/read/38650623/exploring-research-hotspots-and-future-directions-in-neural-tube-defects-field-by-bibliometric-and-bioinformatics-analysis
#11
JOURNAL ARTICLE
Rui Cao, Yanbing Su, Jianting Li, Ruifang Ao, Xiangchao Xu, Yuxiang Liang, Zhizhen Liu, Qi Yu, Jun Xie
BACKGROUND: Neural tube defects (NTDs) is the most common birth defect of the central nervous system (CNS) which causes the death of almost 88,000 people every year around the world. Much efforts have been made to investigate the reasons that contribute to NTD and explore new ways to for prevention. We trawl the past decade (2013-2022) published records in order to get a worldwide view about NTDs research field. METHODS: 7,437 records about NTDs were retrieved from the Web of Science (WOS) database...
2024: Frontiers in Neuroscience
https://read.qxmd.com/read/38650305/investigation-of-health-effects-of-major-phenolic-compounds-in-foods-extraction-processes-analytical-approaches-and-applications
#12
REVIEW
M Mesud Hurkul, Ahmet Cetinkaya, S Irem Kaya, Seyda Yayla, Sibel A Ozkan
The escalating costs of healthcare services and a growing awareness of personal health responsibilities have led individuals to explore natural methods alongside conventional medicines for health improvement and disease prevention. The aging global population is experiencing increased health needs, notably related to conditions like diabetes, heart disease, and hypertension. Lifestyle-related diseases, poor dietary habits, and sedentary lifestyles underscore the importance of foods containing nutrients that can aid in preventing and managing these diseases...
April 22, 2024: Critical Reviews in Analytical Chemistry
https://read.qxmd.com/read/38650006/predictive-significance-of-fgfr4-p-g388r-polymorphism-in-metastatic-colorectal-cancer-patients-receiving-trifluridine-tipiracil-tas-102-treatment
#13
JOURNAL ARTICLE
Alessandro Ottaiano, Mariachiara Santorsola, Monica Ianniello, Anna Ceccarelli, Marika Casillo, Francesco Sabbatino, Nadia Petrillo, Marco Cascella, Francesco Caraglia, Carmine Picone, Francesco Perri, Roberto Sirica, Silvia Zappavigna, Guglielmo Nasti, Giovanni Savarese, Michele Caraglia
BACKGROUND: TAS-102 (Lonsurf® ) is an oral fluoropyrimidine consisting of a combination of trifluridine (a thymidine analog) and tipiracil (a thymidine phosphorylation inhibitor). The drug is effective in metastatic colorectal cancer (mCRC) patients refractory to fluorouracil, irinotecan and oxaliplatin. This study is a real-world analysis, investigating the interplay of genotype/phenotype in relation to TAS-102 sensitivity. METHODS: Forty-seven consecutive mCRC patients were treated with TAS-102 at the National Cancer Institute of Naples from March 2019 to March 2021, at a dosage of 35 mg/m2 , twice a day, in cycles of 28 days (from day 1 to 5 and from day 8 to 12)...
April 22, 2024: Journal of Translational Medicine
https://read.qxmd.com/read/38649544/the-role-of-urology-and-radiology-in-prostate-biopsy-current-trends-and-future-perspectives
#14
REVIEW
Benjamin M Mac Curtain, Hugo C Temperley, John A O Kelly, James Ryan, Wanyang Qian, Niall O'Sullivan, Kieran J Breen, Colin J Mc Carthy, Ian Brennan, Niall F Davis
PURPOSE: Prostate biopsy is central to the accurate histological diagnosis of prostate cancer. In current practice, the biopsy procedure can be performed using a transrectal or transperineal route with different technologies available for targeting of lesions within the prostate. Historically, the biopsy procedure was performed solely by urologists, but with the advent of image-guided techniques, the involvement of radiologists in prostate biopsy has become more common. Herein, we discuss the pros, cons and future considerations regarding their ongoing role...
April 22, 2024: World Journal of Urology
https://read.qxmd.com/read/38648027/follicular-infundibular-tricholemmal-squamous-cell-carcinoma-a-new-who-entity-clinicopathological-features-in-103-cases-including-follow-up-and-implications-for-patient-management
#15
JOURNAL ARTICLE
Richard A Carr, James Wiggins, David N Slater
AIMS: Cutaneous follicular (infundibular-tricholemmal) squamous cell carcinoma (FSCC) is a new World Health Organization entity. We present the largest series of published cases, summarizing clinical data, diagnostic criteria, differential diagnosis, and implications for patient management. METHODS: Cases were identified from 2004 to 2011. Inclusion criteria included discrete attachment(s) of the tumor to the overlying epidermis via follicular infundibula, tricholemmal keratinization, and cellular pleomorphism...
April 23, 2024: American Journal of Dermatopathology
https://read.qxmd.com/read/38647968/an-overview-of-fermentation-in-the-food-industry%C3%A2-looking-back-from-a-new-perspective
#16
REVIEW
Shahida Anusha Siddiqui, Zeki Erol, Jerina Rugji, Fulya Taşçı, Hatice Ahu Kahraman, Valeria Toppi, Laura Musa, Giacomo Di Giacinto, Nur Alim Bahmid, Mohammad Mehdizadeh, Roberto Castro-Muñoz
Fermentation is thought to be born in the Fertile Crescent, and since then, almost every culture has integrated fermented foods into their dietary habits. Originally used to preserve foods, fermentation is now applied to improve their physicochemical, sensory, nutritional, and safety attributes. Fermented dairy, alcoholic beverages like wine and beer, fermented vegetables, fruits, and meats are all highly valuable due to their increased storage stability, reduced risk of food poisoning, and enhanced flavor...
November 28, 2023: Bioresources and Bioprocessing
https://read.qxmd.com/read/38647728/predicting-contralateral-extraprostatic-extension-in-unilateral-high-risk-prostate-cancer-a-multicentric-external-validation-study
#17
JOURNAL ARTICLE
Romain Diamand, Jean-Baptiste Roche, Vito Lacetera, Giuseppe Simone, Olivier Windisch, Daniel Benamran, Alexandre Fourcade, Georges Fournier, Gaelle Fiard, Guillaume Ploussard, Thierry Roumeguère, Alexandre Peltier, Simone Albisinni
PURPOSE: Accurate prediction of extraprostatic extension (EPE) is crucial for decision-making in radical prostatectomy (RP), especially in nerve-sparing strategies. Martini et al. introduced a three-tier algorithm for predicting contralateral EPE in unilateral high-risk prostate cancer (PCa). The aim of the study is to externally validate this model in a multicentric European cohort of patients. METHODS: The data from 208 unilateral high-risk PCa patients diagnosed through magnetic resonance imaging (MRI)-targeted and systematic biopsies, treated with RP between January 2016 and November 2021 at eight referral centers were collected...
April 22, 2024: World Journal of Urology
https://read.qxmd.com/read/38647689/the-impact-of-mpmri-targeted-vs-systematic-biopsy-on-the-risk-of-prostate-cancer-downgrading-at-final-pathology
#18
JOURNAL ARTICLE
G Sorce, A Stabile, F Pellegrino, E Mazzone, A Mattei, L Afferi, S Serni, A Minervini, M Roumiguiè, B Malavaud, M Valerio, A Rakauskas, G Marra, P Gontero, F Porpiglia, H Guo, J Zhuang, G Gandaglia, F Montorsi, A Briganti
PURPOSE: Although targeted biopsies (TBx) are associated with improved disease assessment, concerns have been raised regarding the risk of prostate cancer (PCa) overgrading due to more accurate biopsy core deployment in the index lesion. METHODS: We identified 1672 patients treated with radical prostatectomy (RP) with a positive mpMRI and ISUP ≥ 2 PCa detected via systematic biopsy (SBx) plus TBx. We compared downgrading rates at RP (ISUP 4-5, 3, and 2 at biopsy, to a lower ISUP) for PCa detected via SBx only (group 1), via TBx only (group 2), and eventually for PCa detected with the same ISUP 2-5 at both SBx and TBx (group 3), using multivariable logistic regression models (MVA)...
April 22, 2024: World Journal of Urology
https://read.qxmd.com/read/38647237/development-of-m6a-m5c-m1a-regulated-lncrna-signature-for-prognostic-prediction-personalized-immune-intervention-and-drug-selection-in-luad
#19
JOURNAL ARTICLE
Chao Ma, Zhuoyu Gu, Yang Yang
Research indicates that there are links between m6A, m5C and m1A modifications and the development of different types of tumours. However, it is not yet clear if these modifications are involved in the prognosis of LUAD. The TCGA-LUAD dataset was used as for signature training, while the validation cohort was created by amalgamating publicly accessible GEO datasets including GSE29013, GSE30219, GSE31210, GSE37745 and GSE50081. The study focused on 33 genes that are regulated by m6A, m5C or m1A (mRG), which were used to form mRGs clusters and clusters of mRG differentially expressed genes clusters (mRG-DEG clusters)...
April 2024: Journal of Cellular and Molecular Medicine
https://read.qxmd.com/read/38647223/comparing-gastrointestinal-stromal-tumor-outcomes-between-geriatric-and-non-geriatric-patients-a%C3%A2-population-based-analysis
#20
JOURNAL ARTICLE
Abhiram Singh, Bhargava Chitti, Christopher Aguiar, A Gabriella Wernicke, Craig E Devoe, Husneara Rahman, Cristina Sison, Bhupesh Parashar
BACKGROUND: Gastrointestinal Stromal Tumors (GISTs) are the most common mesenchymal tumors of the GI tract. SEER is an extensive cancer database which proves useful in analyzing population trends. This analysis investigated GIST outcomes between geriatric & non-geriatric patients. METHODS: SEER*STAT 8.4.0.1 was used to extract relevant GIST data from 2000 to 2019. Geriatric age was defined as ≥70 years. Variables included age, sex, surgery, cancer-specific death, and overall survival...
April 22, 2024: World Journal of Surgery
keyword
keyword
103180
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.